
ODAC Votes for Accelerated Approval of Pertuzumab as First Neoadjuvant Treatment for Breast Cancer
Author(s) -
Peggy Eastman
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000436583.73132.7a
Subject(s) - pertuzumab , breast cancer , oncology , medicine , neoadjuvant therapy , cancer , trastuzumab